Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Abstract Department of Medicine Grand Rounds is another installment of our "Year in Review" Series. This series highlights practice-changing updates in various medical fields, and in this session we will be hearing from some of our experts in Cardiology.

Topic: "Cardiac Electrophysiology”
Presented by: Konstantinos N. Aronis, MD PhD

Topic: “A Lipids and Cardiovascular Disease Prevention Update”
Presented by: Anum Saeed, MD

Topic: “Review of Two Trials - Understanding and management of coronary and ischemic heart diasease, and assessing a therapeutic approach”
Presented by: Natalie Stokes, MD MPhil

Upon completion of this activity, participants should be able to:

• Describe the benefits of rhythm vs. rate control in patients with early onset of atrial fibrillation
• Review the benefits of catheter ablation as a first line therapy in patients with cardiomyopathy presenting with ventricular tachycardia
• Define what conduction system pacing is and how can it benefit patients with heart failure who meet criteria for cardiac resynchronization therapy
• Improve cardiovascular disease outcomes by understanding on lipoprotein(a) testing and cardiovascular diseases
• Optimize cardiovascular care by adequate residual risk assessment and prevention strategies
• Improve utilization of statin and non statin therapies in lowering cardiovascular disease risk
• Improve patient outcomes through better triage of patients appropriate for invasive management of ischemic heart disease
• Improve clinician performance in medical management for patients with ischemic heart disease
• Improve physician knowledge on options for testing for patients with suspicion of ischemic heart disease

Suggested Additional Reading

• Kirchhof P et al. N Engl J Med 2020;383:1305-16
• Arenal A et al. J Am Coll Cardiol 2022;79:1441–1453 
• Tung R et al. Circulation 2022;145:1839–1849
• Wang Y et al. J Am Coll Cardiol 2022;80:1205–121 
• Vijayaraman P et al. Heart Rhythm 2022;19:1263–1271

• https://www.nejm.org/doi/full/10.1056/NEJMoa2211023 

• https://jamanetwork.com/journals/jama/fullarticle/2790913 
  
• https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.120.007485?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
• Perera D, Clayton T, Petrie M, et al. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial. J Am Coll Cardiol HF. 2018 Jun, 6 (6) 517–526. https://doi.org/10.1016/j.jchf.2018.01.024
• Vergallo R, Volpe M. The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain? Eur Heart J. 2022 Jun 1;43(21):2008-2009. doi: 10.1093/eurheartj/ehac193. PMID: 35417531.
• Hochman JS, Anthopolos R, Reynolds HR, et al. Survival after invasive or conservative management of stable coronary disease. Circulation. 2022;Epub ahead or print.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.